Sulfonylurea Blockade of KATP Channels Unmasks a Distinct Type of Glucose-Induced Ca2+ Decrease in Pancreatic β-Cells

Pancreas. 2017 Apr;46(4):467-475. doi: 10.1097/MPA.0000000000000777.

Abstract

Objectives: This study aimed to explore how sulfonylurea blockade of KATP channels affects the early Ca signals for glucose generation of insulin release.

Methods: Cytoplasmic Ca was measured with ratiometric microfluorometry in isolated mouse islets loaded with Fura-PE3.

Results: After sulfonylurea blockade of the KATP channels (50 μM-1 mM tolbutamide or 1 μM-1 mM gliclazide), increase of glucose from 3 to 20 mM resulted in suppression of elevated Ca during a 3- to 5-minute period. The Ca decrease was shorter after inhibition of the Na/K pump with ouabain (10 and 100 μM) but prolonged when the α2A adrenoceptors were activated with clonidine (1 and 10 nM) or epinephrine (10 nM). Inhibition of the sarco/endoplasmic reticulum Ca-ATPase pump with 10 μM cyclopiazonic acid counteracted the action of 10 nM clonidine, making the Ca decrease shorter than in controls. Extended superfusion of islets with a medium containing 20 mM glucose and 1 mM tolbutamide sometimes resulted in delayed appearance of Ca oscillations mediated by periodic interruption of elevated Ca.

Conclusions: Increase of glucose generates prompt suppression of cytoplasmic Ca in β-cells lacking functional KATP channels. Activation of α2A adrenoceptors markedly prolongs the period of glucose-induced Ca decrease, an effect counteracted by cyclopiazonic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / pharmacology
  • Animals
  • Calcium / metabolism*
  • Cells, Cultured
  • Clonidine / pharmacology
  • Female
  • Gliclazide / pharmacology
  • Glucose / pharmacology*
  • Hypoglycemic Agents / pharmacology
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism
  • KATP Channels / antagonists & inhibitors*
  • KATP Channels / metabolism
  • Mice, Inbred C57BL
  • Receptors, Adrenergic, alpha-2 / metabolism
  • Sulfonylurea Compounds / pharmacology*
  • Time Factors
  • Tolbutamide / pharmacology

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Hypoglycemic Agents
  • KATP Channels
  • Receptors, Adrenergic, alpha-2
  • Sulfonylurea Compounds
  • Tolbutamide
  • Gliclazide
  • Glucose
  • Clonidine
  • Calcium